Galcanezumab effects on incidence of headache after occurrence of triggers, premonitory symptoms, and aura in responders, non-responders, super-responders, and super non-responders

Peer Review reports

Original Submission
10 Feb 2023	Submitted	Original manuscript
23 Feb 2023	Reviewed	Reviewer Report
26 Feb 2023	Reviewed	Reviewer Report - Andreas R. Gantenbein
2 Mar 2023	Author responded	Author comments - Rami Burstein
Resubmission - Version 2
2 Mar 2023	Submitted	Manuscript version 2
Publishing
3 Mar 2023	Editorially accepted
16 Mar 2023	Article published	10.1186/s10194-023-01560-x

Back to article page